Advanced Wound Dressing Market

Market Overview

The global advanced wound dressing market size is valued at USD 6.9 billion in 2021 and is predicted to reach USD 11.9 billion by 2030, representing a CAGR of 6.02% over the forecast period (2022–2030).

 Items for treating acute and chronic wounds, such as lesions, burns, and post-operative injuries, are included in advanced wound care. Advanced wound care treatments such as film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound moist and accelerate healing without obstructing the process. The advanced wound care industry can help people with chronic wounds by providing them with easily accessible and reasonably priced items that they can use at their leisure. Chronic wounds are becoming more common, surgeries are becoming more common, and technological advancements are driving the market forward.

Due to developments in technology, an increase in surgical operations, and an increase in the occurrence of chronic wounds worldwide, there is a growing demand for sophisticated wound dressing. The rising prevalence of chronic diseases like diabetes, cancer, and other autoimmune diseases drives the demand for advanced wound dressing. One of the leading causes of the rise in non-communicable diseases is variables like antimicrobial resistance, adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking.

Market Dynamics

Market Drivers

• Increase in Prevalence of Chronic Diseases

The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases. Antimicrobial resistance, the adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are all key contributors to the prevalence of non-communicable illnesses. According to National Diabetes Statistic Report 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100.0 million people in the US were living with diabetes or prediabetes conditions. Furthermore, the World Health Organization estimates that diabetes caused nearly 1.6 million deaths worldwide in 2016.

The number of procedures performed has increased due to the rising frequency of chronic illnesses. As a result, wound care solutions are utilized more frequently to avoid surgical site infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudates that must be handled often—advanced wound dressings including hydrogel, alginate, and foam aid in wound management and infection prevention. As a result, increased chronic illness incidence is predicted to enhance demand for wound care products, pushing market expansion.

• Rising Number of Accidents

The market is expected to develop due to an increase in the number of incidents such as car accidents, burns, and trauma events occurring around the world. According to the WHO (2018), over 1,000,000 individuals are severely or moderately burned in India. Furthermore, according to NCBI, the incidence of burn wounds increased in 2017 in countries such as Bulgaria, Finland, the Netherlands, China, Australia, and the United Kingdom. Furthermore, the American Association for the Surgery of Trauma estimates that 1.2 million people died in automobile accidents worldwide in 2017, with 3,242 people dying per day. Road accidents are more common in countries with moderate or low income. Thus, the rising number of casualties is expected to boost the demand for advanced wound dressing, likely leading to considerable market growth over the forecast period.

Market Restraint

• Stringent Manufacturing Policies

The US FDA classifies most wound dressing products under Class I medical devices, exempted from premarket approval. A surgical dressing covers open incision wounds; thus, these products must be free from microbial contamination and manufactured in a sterile environment. Any form of microbial contamination may hinder the wound healing process and, in extreme cases, may cause additional infection at the site. Thus, manufacturing companies may not need premarket approval, but they may be required to comply with the Good Manufacturing Practices (GMP). According to these policies, the wound dressing products must be manufactured under sterile conditions. They have to undergo an extensive quality control process before launching the product.

Market Opportunities

• Increasing Demand for Reduced Hospital Stay

The growing workforce for home care services can be ascribed to the rapidly increasing demand for home healthcare services. This is projected to be a significant market driver for improved wound dressings. As per the US Bureau of Labor Statistics, the number of home healthcare and personal care aides in the United States will reach 13 million by 2020. Furthermore, as the senior population grows, home healthcare services will likely become more popular, as older individuals are more inclined to use them.

As per the Population Reference Bureau, the proportion of people aged 65 and up in the United States will rise from 52 million in 2018 to 95 million by 2060. According to this, the geriatric population in the United States will grow from 16% of the total population in 2018 to 23% in 2060. Patients who need surgery must stay in hospitals for extended periods; as a result, most patients choose home treatment for hospital stays. Patients benefit from these services, including personal care and home-delivered meals, among other things. Hence, demand for home healthcare services is predicted to increase, leading to market growth over the forecast period.

Regional Analysis

North America Dominates the Global Market

By region, the global advanced wound dressing market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America dominated the advanced wound dressing market in 2021 and is expected to show a considerable growth rate over the forecast period. It is estimated to reach an expected USD 6,835 million by 2030 at a CAGR of 8.5%. Increasing road accidents, sports injuries, and several key players in the region are anticipated to drive the market growth. In addition, the presence of adequate skilled professionals and highly developed healthcare infrastructure is also expected to drive market growth over the forecast period.

In 2021, the United States had the highest share of the North American advanced wound dressing market. Well-developed healthcare infrastructure, increasing awareness about the usage of advanced wound care products, and several key market players are the primary drivers of the market. In addition, an increase in the number of orthopedic procedures due to the high prevalence of sports injuries is also anticipated to drive the market.

Europe advanced wound dressing market is driven by factors such as the presence of well-established healthcare infrastructure and the availability of skilled professionals. It is estimated to reach an expected USD 2,700 million by 2030 at a CAGR of 4%. Moreover, favorable reimbursement coverage has increased the adoption of surgical procedures. In addition, the increasing geriatric population and rising cases of burns and trauma are also anticipated to drive the market. Thus, Europe advanced wound dressing market is expected to witness significant growth over the forecast period.

Over the projected period, the market for advanced wound dressing is anticipated to expand quickly in Asia Pacific. It is projected that the presence of developing nations like China, India, and Japan will accelerate regional market expansion. Additionally, the region's rising need for improved wound dressings can be linked to these nations' fast-expanding medical tourism sector.

Segmental Analysis

The global advanced wound dressing market share is segmented by product, application, end-user, and region.

By product, the global advanced wound dressing market is divided into foam, hydrocolloid, film, alginate, hydrogel, collagen, and other advanced dressing. The hydrocolloid dressing segment held a significant share in 2021 and is anticipated to witness the fastest growth rate over the forecast period. It is estimated to reach an expected value of USD 2,080 million by 2030 at a CAGR of 5%. Hydrocolloid dressings are composed of gel-forming agents such as carboxymethylcellulose (CMC) and gelatin. These materials are occlusive, which helps in moisture retention. These dressings promote quick healing and are resistant to bacterial infection. As a result, it aids in wound protection both internally and externally.

Further, growing diabetes cases worldwide are expected to drive category growth over the forecast period. According to the CDC, roughly 5% of adults in the United States were diagnosed with Type 1 diabetes in 2015. Approximately 15% of this diabetic population suffers from diabetic wounds or diabetic ulcers. As a result, demand for hydrocolloid wound dressing is predicted to increase over the forecast period.

the foam dressing segment has a significant share of the global market. Throughout the projection period, the segment is anticipated to increase significantly. Foam dressings are constructed of hydrophilic polyurethane, a highly absorbent substance. The foam assists in absorbing the moisture that helps to preserve the tissue's integrity. The U.S.'s rising burn and trauma cases are anticipated to fuel the segment's expansion. For instance, according to the American Burn Association (ABA), 486,000 Americans received medical care for burn injuries in 2016. Additionally, it stated that individuals with burns accounted for the highest rate of infection-related problems.

By application, the global advanced wound dressing market is divided into chronic and acute wounds. The acute wound segment held the largest market share in 2021. It is estimated to reach an expected value of USD 6,430 million by 2030 at a CAGR of 4.5%. The acute wounds comprise surgical and traumatic wounds and burns. The surgical and traumatic wounds segment held the largest share, owing to the increasing cases of trauma in the US. As per the World Health Organization (WHO), in 2019, around 9% of global mortality occurs due to trauma every year.

The chronic wounds segment is anticipated to witness considerable growth over the forecast period. The country's growing geriatric population and the rising incidence of chronic diseases, particularly diabetes, are the main drivers of the segment's growth. For instance, according to the United States Census Bureau, the population of people 65 and older increased by 1.6 million between 2016 and 2017. The segment is further separated into pressure ulcers, venous leg ulcers, diabetic foot ulcers, and others.

By end-user, the global advanced wound dressing market is divided into hospitals, specialty clinics, home healthcare, and others. The hospital segment dominated the market. It is estimated to reach an expected value of USD 4,850 million by 2030 at a CAGR of 4.5%. The rising prevalence of diabetic foot ulcers and venous leg ulcers is the primary segment expansion driver. Furthermore, the increasing likelihood of surgical wounds due to the expanding number of surgeries is propelling the industry forward. SSI wounds are usually treated using advanced wound dressing. As a result, such variables may boost segment growth during the predicted period.

Over the projected period, home healthcare is anticipated to develop at the fastest rate. Most procedures have a lengthy healing phase, which necessitates regular dressing changes. As a result, there is a rising need for improved wound care solutions in home healthcare settings. Additionally, patients with chronic wounds, those who are geriatric or obese, and those who choose home treatment over hospital stays.

Recent Developments

• In November 2022, With the opening of the Smith+Nephew Academy in Singapore, healthcare workers across Asia-Pacific will have access to medical education and digital innovation.
• In September 2022, Smith+Nephew introduced the OR3OTM Dual Mobility System for primary and revision hip arthroplasty in Japan. Smith+Nephew introduces the OR3OTM Dual Mobility System in Japan for primary and revision hip arthroplasty.
• In August 2022, To satisfy future supply and sustainability demands, Mölnlycke invested EUR 50 million in a new surgical glove manufacturing facility.
• In May 2022, Convatec finances the creation of cutting-edge neuromodulation technology through investing in BlueWind Medical.